The QbD Group acquires Turnstone Communications and BioVox to strengthen its specialist science communication and marketing services Wilrijk/Ghent, Belgium, 25 May 2023 – The QbD Group, a privately held company offering comprehensive support to life science companies […] May 25, 2023 · Turnstone Communications
V-Bio Ventures portfolio company Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic Use of proceeds will enable the development of the Company’s lead autoimmune program DT-001, targeting TNFR2, as well as its […] May 15, 2023 · V-Bio Ventures
BioVox: the global network for Belgian life sciences turns five and launches a new website! May 4, 2020 · Turnstone Communications
PharmaFluidics awarded VLAIO research grant Funding will support product range extension of micro-chip based µPAC™ nano, capillary and microflow LC columns, and accelerated development of […] June 2, 2020 · Turnstone Communications
Max Planck researchers feed Proteome AI with PharmaFluidics technology Micro-chip based µPAC™ LC columns – key component in NATURE study doubling the universe of known proteins across all kingdoms […] June 18, 2020 · Turnstone Communications
Anacura, a Belgian biotech company, sells stem cell business to Boehringer Ingelheim Ghent, Belgium, 27 July 2020 – GST, the stem cell specialist for horses and pets within the Anacura Group, has […] July 27, 2020 · Turnstone Communications
V-Bio invests into ExeVir Bio to accelerate development of new treatment conferring broad protection against Covid-19 Ghent, Belgium, 28 July 2020 – Today V-Bio Ventures announces its investment in a EUR 23 million Series A financing into ExeVir Bio. […] July 28, 2020 · V-Bio Ventures
Lewis Cantley awarded Dr. Paul Janssen Award for Biomedical Research 2020 Johnson & Johnson Celebrates Role of Scientists In Society with 2020 Dr. Paul Janssen Award for Biomedical Research, Part of […] August 21, 2020 · Janssen Pharmaceutica
Newton Biocapital I invests in J-Pharma Co., Ltd. in Japan focusing on drug development targeting L-type Amino Acid Transporter 1 (LAT1) for cancer and autoimmune diseases Brussels, Belgium / Tokyo, Japan – 27 August 2020 – Newton Biocapital I (“Newton”), an investment company in life sciences, […] August 27, 2020 · Turnstone Communications
Biodol Therapeutics receives EUR 4.5 million to progress its novel pain medication in a Series A led by V-Bio Ventures V-Bio Ventures, a leading Belgian life sciences VC, invests in Biodol Therapeutics, a French biotech specialized in next-generation chronic pain […] August 31, 2020 · V-Bio Ventures
Montis Biosciences appoints Karen Zinkewich-Péotti as Chief Executive Officer Leuven, Belgium, 29 September 2020 – Montis Biosciences, a discovery stage biotech company focused on novel immuno-oncology therapeutics targeting the […] September 29, 2020 · Turnstone Communications
V-Bio Ventures invests in new start-up Animab in a EUR 3.4 million Seed Financing to improve health and performance of livestock animals Gent, Belgium, 27 October 2020 – Today V-Bio Ventures announces its investment in Animab, a new venture spin-off from VIB, in a EUR […] October 27, 2020 · V-Bio Ventures
Newton Biocapital I invests in Perseus Proteomics Inc. in Japan to develop therapeutic antibodies for the treatment of blood cancers Brussels, Belgium / Tokyo, Japan – 1 December 2020 – Newton Biocapital I (“Newton”), a life sciences investment fund active in Europe […] December 1, 2020 · Turnstone Communications
eTheRNA and China Grand Pharma enter a strategic collaboration in the Greater China Region focussed on eTheRNA’s proprietary mRNA development products and manufacturing capabilities Niel, Belgium, 1 December 2020 – eTheRNA immunotherapies NV (“eTheRNA”) announced it has entered into a strategic cooperation and product […] December 2, 2020 · Turnstone Communications
DoseVue obtains CE Mark for its first in-vivo dosimetry product for radiation therapy Diepenbeek, Belgium – January 28, 2021 – DoseVue NV, a privately held medical device company developing in-vivo dosimetry solutions for […] January 28, 2021 · Turnstone Communications
